HOME Research Insight Agreements, Collaborations, and Contracts Accounted for the Major Share of the Total Key Growth Strategies Adopted by Players Operating in the Collagen and Gelatin Market



Agreements, Collaborations, and Contracts Accounted for the Major Share of the Total Key Growth Strategies Adopted by Players Operating in the Collagen and Gelatin Market


The global collagen market for regenerative medicine is projected to grow from USD 420.6 Million in 2017 to USD 679.9 Million by 2022, at a CAGR of 10.1%. The global gelatin market for regenerative medicine is projected to grow from USD 65.2 Million in 2017 to USD 94.9 Million by 2022, at a CAGR of 7.8%. In 2016, the major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). Similarly, the major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).

Agreements, collaborations, and contracts accounted for the major share of the total key growth strategies adopted by players operating in the collagen and gelatin market for regenerative medicine during 2014 to 2017. This strategy was adopted to strengthen their presence in various geographies. The key players who adopted this strategy include Collagen Solutions plc (U.K.) and Integra LifeSciences Holding Corporation (U.S.).

Acquisitions accounted as one of the key growth strategies followed by players in the collagen and gelatin market for regenerative medicine from 2014 to 2017. Acquisitions were aimed at upgrading facilities, expanding their product portfolio, and catering to the needs of the growing customer base. The key players who adopted this strategy are Collagen Solutions plc (U.K.) and Integra LifeSciences Holding Corporation (U.S.).

Approvals also accounted for one of the strategic developments undertaken by market players during 2014 to 2017. The key players adopted this strategy to develop, commercialize, and expand their product portfolio, so as to strengthen their customer base and provide better products to their clients. Collagen Matrix, Inc. (U.S.) and Integra LifeSciences Holding Corporation (U.S.) adopted this strategy.

Few of the instances of the strategies followed by the players have been discussed below:

  • In April 2017, Collagen Solutions entered into an agreement with Smart Matrix Limited (SML) (U.K.), a provider of wound healing products, for the development and manufacturing of Smart Matrix, a wound care scaffold used to close full-thickness wounds and regenerate the dermis.
  • In January 2017, Integra LifeSciences Holding Corporation acquired Derma Sciences, Inc. (U.S.), a tissue regeneration company that focuses on advanced wound and burn care. This acquisition enabled Integra to expand its capabilities in regenerative technology with the addition of Derma Sciences’ amniotic tissue-based products.
  • In April 2014, Collagen Matrix, Inc. received FDA 510(K) clearance for its Flexible Collagen Nerve Conduit. The product is meant for the management of peripheral nerve injuries in the foot to reduce the formation of neuromas.
  • In May 2017, GELITA AG received the approval from The Woodbury County Board of Supervisors (U.S.) for its expansion in Sergeant Bluff, Iowa (U.S.). The new facility is expected to be built by the end of 2018 and will be used to manufacture collagen peptides.

Related Reports:

Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports